These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31356028)

  • 1. [Fusion biopsy of the prostate].
    Okishev AV; Govorov AV; Vasilyev AO; Bormotin AV; Pushkar DY
    Urologiia; 2019 Jul; (3):142-148. PubMed ID: 31356028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
    Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
    Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
    Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
    BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
    Siddiqui MM; Rais-Bahrami S; Turkbey B; George AK; Rothwax J; Shakir N; Okoro C; Raskolnikov D; Parnes HL; Linehan WM; Merino MJ; Simon RM; Choyke PL; Wood BJ; Pinto PA
    JAMA; 2015 Jan; 313(4):390-7. PubMed ID: 25626035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
    Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
    Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on prostate biopsy in the era of magnetic resonance imaging.
    Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
    Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.
    Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH
    J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate.
    Oberlin DT; Casalino DD; Miller FH; Matulewicz RS; Perry KT; Nadler RB; Kundu S; Catalona WJ; Meeks JJ
    Urology; 2016 Jun; 92():75-9. PubMed ID: 26966043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
    Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
    Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].
    Durmus T; Stephan C; Grigoryev M; Diederichs G; Saleh M; Slowinski T; Maxeiner A; Thomas A; Fischer T
    Rofo; 2013 May; 185(5):428-33. PubMed ID: 23420313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy.
    Coker MA; Glaser ZA; Gordetsky JB; Thomas JV; Rais-Bahrami S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):549-555. PubMed ID: 29988101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural Invasion in Prostate Cancer Is More Frequently Detected by Multiparametric MRI Targeted Biopsy Compared With Standard Biopsy.
    Gordetsky JB; Nix JW; Rais-Bahrami S
    Am J Surg Pathol; 2016 Apr; 40(4):490-4. PubMed ID: 26523543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
    Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
    Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
    Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
    Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer.
    Del Monte M; Leonardo C; Salvo V; Grompone MD; Pecoraro M; Stanzione A; Campa R; Vullo F; Sciarra A; Catalano C; Panebianco V
    Radiol Med; 2018 Mar; 123(3):227-234. PubMed ID: 29075977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.